eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 7, 2015, Pages 830-835

  Brina, Daniela ^a   Miluzio, Annarita ^a   Ricciardi, Sara ^a,b   Biffo, Stefano ^a,b  

^a INGM   (Italy)

^b DISIT   (Italy)

Author keywords

EIF6; PKC; RACK1

Indexed keywords

EUKARYOTIC INITIATION FACTOR 6; INITIATION FACTOR; UNCLASSIFIED DRUG; EIF6 PROTEIN, HUMAN; ITGB4BP PROTEIN, MOUSE; MTOR PROTEIN, HUMAN; MTOR PROTEIN, MOUSE; SCAND1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE; TUMOR PROTEIN;

BIOGENESIS; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; RIBOSOME; SHWACHMAN SYNDROME; TRANSLATION REGULATION; TUMOR GROWTH; ANIMAL; BONE MARROW DISEASE; EXPERIMENTAL NEOPLASM; GENETICS; LARGE RIBOSOMAL SUBUNIT; LIPOMATOSIS; LYMPHOMA; METABOLISM; MOUSE; PANCREAS EXOCRINE INSUFFICIENCY; PATHOLOGY; PROTEIN SYNTHESIS;

EUKARYOTA; MAMMALIA; MURINAE;

ANIMALS; BONE MARROW DISEASES; EUKARYOTIC INITIATION FACTORS; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOMATOSIS; LYMPHOMA; MICE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PEPTIDE INITIATION FACTORS; PROTEIN BIOSYNTHESIS; RIBOSOME SUBUNITS, LARGE, EUKARYOTIC; TOR SERINE-THREONINE KINASES;

EID: 84930823565     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.09.010     Document Type: Review

References (77)

1. Adams D.R., Ron D., Kiely P.A. RACK1, a multifaceted scaffolding protein: structure and function. Cell Commun. Signal. 2011, 9:22.
2. Barna M., Pusic A., Zollo O., Costa M., Kondrashov N., Rego E., Rao P.H., Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008, 456:971-975.
3. Basu U., Si K., Deng H., Maitra U. Phosphorylation of mammalian eukaryotic translation initiation factor 6 and its Saccharomyces cerevisiae homologue Tif6p: evidence that phosphorylation of Tif6p regulates its nucleocytoplasmic distribution and is required for yeast cell growth. Mol. Cell. Biol. 2003, 23:6187-6199.
4. Basu U., Si K., Warner J.R., Maitra U. The Saccharomyces cerevisiae TIF6 gene encoding translation initiation factor 6 is required for 60S ribosomal subunit biogenesis. Mol. Cell. Biol. 2001, 21:1453-1462.
5. Benelli D., Marzi S., Mancone C., Alonzi T., la Teana A., Londei P. Function and ribosomal localization of aIF6, a translational regulator shared by archaea and eukarya. Nucleic Acids Res. 2009, 37:256-267.
6. Biffo S., Sanvito F., Costa S., Preve L., Pignatelli R., Spinardi L., Marchisio P.C. Isolation of a novel beta4 integrin-binding protein (p27(BBP)) highly expressed in epithelial cells. J. Biol. Chem. 1997, 272:30314-30321.
7. Biswas A., Mukherjee S., Das S., Shields D., Chow C.W., Maitra U. Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6. J. Biol. Chem. 2011, 286:3129-3138.
8. Boocock G.R., Morrison J.A., Popovic M., Richards N., Ellis L., Durie P.R., Rommens J.M. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 2003, 33:97-101.
9. Burwick N., Coats S.A., Nakamura T., Shimamura A. Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood 2012, 120:5143-5152.
10. Bussiere C., Hashem Y., Arora S., Frank J., Johnson A.W. Integrity of the P-site is probed during maturation of the 60S ribosomal subunit. J. Cell Biol. 2012, 197:747-759.
11. Ceci M., Gaviraghi C., Gorrini C., Sala L.A., Offenhauser N., Marchisio P.C., Biffo S. Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature 2003, 426:579-584.
12. Ceci M., Offenhauser N., Marchisio P.C., Biffo S. Formation of nuclear matrix filaments by p27(BBP)/eIF6. Biochem. Biophys. Res. Commun. 2002, 295:295-299.
13. Chaiwatanatorn K., Stamaratis G., Opeskin K., Firkin F., Nandurkar H. Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab. Leuk. Lymphoma 2009, 50:1666-1675.
14. Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I., Liebhaber S.A., Pasquinelli A.E., Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007, 447:823-828.
15. De Marco N., Iannone L., Carotenuto R., Biffo S., Vitale A., Campanella C. p27(BBP)/eIF6 acts as an anti-apoptotic factor upstream of Bcl-2 during Xenopus laevis development. Cell Death Differ. 2010, 17:360-372.
16. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10762-10767.
17. Donadini A., Giodini A., Sanvito F., Marchisio P.C., Biffo S. The human ITGB4BP gene is constitutively expressed in vitro, but highly modulated in vivo. Gene 2001, 266:35-43.
18. Eulalio A., Huntzinger E., Izaurralde E. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat. Struct. Mol. Biol. 2008, 15:346-353.
19. Fatica A., Tollervey D. Making ribosomes. Curr. Opin. Cell Biol. 2002, 14:313-318.
20. Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011, 25:917-929.
21. Gandin V., Miluzio A., Barbieri A.M., Beugnet A., Kiyokawa H., Marchisio P.C., Biffo S. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008, 455:684-688.
22. Gartmann M., Blau M., Armache J.P., Mielke T., Topf M., Beckmann R. Mechanism of eIF6-mediated inhibition of ribosomal subunit joining. J. Biol. Chem. 2010, 285:14848-14851.
23. Groft C.M., Beckmann R., Sali A., Burley S.K. Crystal structures of ribosome anti-association factor IF6. Nat. Struct. Biol. 2000, 7:1156-1164.
24. Guo J., Wang S., Valerius O., Hall H., Zeng Q., Li J.F., Weston D.J., Ellis B.E., Chen J.G. Involvement of Arabidopsis RACK1 in protein translation and its regulation by abscisic acid. Plant Physiol. 2011, 155:370-383.
25. Harris M.N., Ozpolat B., Abdi F., Gu S., Legler A., Mawuenyega K.G., Tirado-Gomez M., Lopez-Berestein G., Chen X. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 2004, 104:1314-1323.
26. Hock J., Weinmann L., Ender C., Rudel S., Kremmer E., Raabe M., Urlaub H., Meister G. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep. 2007, 8:1052-1060.
27. Huang W., Bansode R., Mehta M., Mehta K.D. Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance. Hepatology 2009, 49:1525-1536.
28. Jackson R.J., Hellen C.U., Pestova T.V. Termination and post-termination events in eukaryotic translation. Adv. Protein Chem. Struct. J. 2012, 86:45-93.
29. Kettenbach A.N., Schweppe D.K., Faherty B.K., Pechenick D., Pletnev A.A., Gerber S.A. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci. Signal. 2011, 4. (rs5).
30. Klinge S., Voigts-Hoffmann F., Leibundgut M., Arpagaus S., Ban N. Crystal structure of the eukaryotic 60S ribosomal subunit in complex with initiation factor 6. Science 2011, 334:941-948.
31. Kondrashov N., Pusic A., Stumpf C.R., Shimizu K., Hsieh A.C., Xue S., Ishijima J., Shiroishi T., Barna M. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 2011, 145:383-397.
32. Lebreton A., Saveanu C., Decourty L., Rain J.C., Jacquier A., Fromont-Racine M. A functional network involved in the recycling of nucleocytoplasmic pre-60S factors. J. Cell Biol. 2006, 173:349-360.
33. Lempiainen H., Shore D. Growth control and ribosome biogenesis. Curr. Opin. Cell Biol. 2009, 21:855-863.
34. Loreni F., Mancino M., Biffo S. Translation factors and ribosomal proteins control tumor onset and progression: how?. Oncogene 2014, 33:2145-2156.
35. Mackay H.J., Twelves C.J. Targeting the protein kinase C family: are we there yet?. Nat. Rev. Cancer 2007, 7:554-562.
36. Martin B., Sanz R., Aragues R., Oliva B., Sierra A. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments. J. Proteome Res. 2008, 7:3242-3253.
37. McKinney C., Zavadil J., Bianco C., Shiflett L., Brown S., Mohr I. Global reprogramming of the cellular translational landscape facilitates cytomegalovirus replication. Cell Rep. 2014, 6:9-17.
38. Menne T.F., Goyenechea B., Sanchez-Puig N., Wong C.C., Tonkin L.M., Ancliff P.J., Brost R.L., Costanzo M., Boone C., Warren A.J. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 2007, 39:486-495.
39. Miluzio A., Beugnet A., Grosso S., Brina D., Mancino M., Campaner S., Amati B., de Marco A., Biffo S. Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth. Cancer Cell 2011, 19:765-775.
40. Miluzio A., Beugnet A., Volta V., Biffo S. Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation. EMBO Rep. 2009, 10:459-465.
41. Morley S.J., Traugh J.A. Stimulation of translation in 3T3-L1 cells in response to insulin and phorbol ester is directly correlated with increased phosphate labelling of initiation factor (eIF-) 4F and ribosomal protein S6. Biochimie 1993, 75:985-989.
42. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
43. Nilsson J., Sengupta J., Frank J., Nissen P. Regulation of eukaryotic translation by the RACK1 protein: a platform for signalling molecules on the ribosome. EMBO Rep. 2004, 5:1137-1141.
44. Oh C.K., Filler S.G., Cho S.H. Eukaryotic translation initiation factor-6 enhances histamine and IL-2 production in mast cells. J. Immunol. 2001, 166:3606-3611.
45. Orr S.J., Boutz D.R., Wang R., Chronis C., Lea N.C., Thayaparan T., Hamilton E., Milewicz H., Blanc E., Mufti G.J., et al. Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry. Mol. Syst. Biol. 2012, 8:573.
46. Phanstiel D.H., Brumbaugh J., Wenger C.D., Tian S., Probasco M.D., Bailey D.J., Swaney D.L., Tervo M.A., Bolin J.M., Ruotti V., et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 2011, 8:821-827.
47. Pisarev A.V., Skabkin M.A., Pisareva V.P., Skabkina O.V., Rakotondrafara A.M., Hentze M.W., Hellen C.U., Pestova T.V. The role of ABCE1 in eukaryotic posttermination ribosomal recycling. Mol. Cell 2010, 37:196-210.
48. Podar K., Anderson K.C. Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies. Curr. Cancer Drug Targets 2011, 11:1005-1024.
49. Post S.M., Quintas-Cardama A., Terzian T., Smith C., Eischen C.M., Lozano G. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene 2010, 29:1260-1269.
50. Pressato B., Valli R., Marletta C., Mare L., Montalbano G., Lo Curto F., Pasquali F., Maserati E. Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis. Br. J. Haematol. 2012, 157:503-505.
51. Proud C.G. Regulation of protein synthesis by insulin. Biochem. Soc. Trans. 2006, 34:213-216.
52. Ray P., Basu U., Ray A., Majumdar R., Deng H., Maitra U. The Saccharomyces cerevisiae 60S ribosome biogenesis factor Tif6p is regulated by Hrr25p-mediated phosphorylation. J. Biol. Chem. 2008, 283:9681-9691.
53. Ron D., Chen C.H., Caldwell J., Jamieson L., Orr E., Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:839-843.
54. Rosso P., Cortesina G., Sanvito F., Donadini A., Di Benedetto B., Biffo S., Marchisio P.C. Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck 2004, 26:408-417.
55. Ruan Y., Sun L., Hao Y., Wang L., Xu J., Zhang W., Xie J., Guo L., Zhou L., Yun X., et al. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J. Clin. Invest. 2012, 122:2554-2566.
56. Ruggero D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 2013, 5.
57. Russell D.W., Spremulli L.L. Mechanism of action of the wheat germ ribosome dissociation factor: interaction with the 60S subunit. Arch. Biochem. Biophys. 1980, 201:518-526.
58. Sanvito F., Piatti S., Villa A., Bossi M., Lucchini G., Marchisio P.C., Biffo S. The beta4 integrin interactor p27(BBP/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly. J. Cell Biol. 1999, 144:823-837.
59. Sanvito F., Vivoli F., Gambini S., Santambrogio G., Catena M., Viale E., Veglia F., Donadini A., Biffo S., Marchisio P.C. Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. Cancer Res. 2000, 60:510-516.
60. Schaffel R., Morais J.C., Biasoli I., Lima J., Scheliga A., Romano S., Milito C., Spector N. PKC-beta II expression has prognostic impact in nodal diffuse large B-cell lymphoma. Mod. Pathol. 2007, 20:326-330.
61. Senger B., Lafontaine D.L., Graindorge J.S., Gadal O., Camasses A., Sanni A., Garnier J.M., Breitenbach M., Hurt E., Fasiolo F. The nucle(ol)ar Tif6p and Efl1p are required for a late cytoplasmic step of ribosome synthesis. Mol. Cell 2001, 8:1363-1373.
62. Sengupta J., Nilsson J., Gursky R., Spahn C.M., Nissen P., Frank J. Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat. Struct. Mol. Biol. 2004, 11:957-962.
63. Sharma G., Pallesen J., Das S., Grassucci R., Langlois R., Hampton C.M., Kelly D.F., des Georges A., Frank J. Affinity grid-based cryo-EM of PKC binding to RACK1 on the ribosome. J. Struct. Biol. 2013, 181:190-194.
64. Si K., Chaudhuri J., Chevesich J., Maitra U. Molecular cloning and functional expression of a human cDNA encoding translation initiation factor 6. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14285-14290.
65. Si K., Maitra U. The Saccharomyces cerevisiae homologue of mammalian translation initiation factor 6 does not function as a translation initiation factor. Mol. Cell. Biol. 1999, 19:1416-1426.
66. Silvera D., Formenti S.C., Schneider R.J. Translational control in cancer. Nat. Rev. Cancer 2010, 10:254-266.
67. Skabkin M.A., Skabkina O.V., Hellen C.U., Pestova T.V. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol. Cell 2013, 51:249-264.
68. Stebbins E.G., Mochly-Rosen D. Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. J. Biol. Chem. 2001, 276:29644-29650.
69. Tarnowski K., Fituch K., Szczepanowski R.H., Dadlez M., Kaus-Drobek M. Patterns of structural dynamics in RACK1 protein retained throughout evolution: a hydrogen-deuterium exchange study of three orthologs. Protein Sci. 2014, 23:639-651.
70. Valenzuela D.M., Chaudhuri A., Maitra U. Eukaryotic ribosomal subunit anti-association activity of calf liver is contained in a single polypeptide chain protein of Mr=25,500 (eukaryotic initiation factor 6). J. Biol. Chem. 1982, 257:7712-7719.
71. Valli R., Pressato B., Marletta C., Mare L., Montalbano G., Curto F.L., Pasquali F., Maserati E. Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms. Mol. Cytogenet. 2013, 6:56.
72. Volta V., Beugnet A., Gallo S., Magri L., Brina D., Pesce E., Calamita P., Sanvito F., Biffo S. RACK1 depletion in a mouse model causes lethality, pigmentation deficits and reduction in protein synthesis efficiency. Cell. Mol. Life Sci. 2013, 70:1439-1450.
73. Volta V., Ceci M., Emery B., Bachi A., Petfalski E., Tollervey D., Linder P., Marchisio P.C., Piatti S., Biffo S. Sen34p depletion blocks tRNA splicing in vivo and delays rRNA processing. Biochem. Biophys. Res. Commun. 2005, 337:89-94.
74. Wick W., Weller M., Weiler M., Batchelor T., Yung A.W., Platten M. Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro-Oncology 2011, 13:566-579.
75. Witzig T.E., Gupta M. Signal transduction inhibitor therapy for lymphoma. Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program 2010, 265-270. (2010).
76. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
77. Wood L.C., Ashby M.N., Grunfeld C., Feingold K.R. Cloning of murine translation initiation factor 6 and functional analysis of the homologous sequence YPR016c in Saccharomyces cerevisiae. J. Biol. Chem. 1999, 274:11653-11659.